Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jos A van Strijp"'
Autor:
Stephen W Tuffs, David B A James, Jovanka Bestebroer, Amy C Richards, Mariya I Goncheva, Marie O'Shea, Bryan A Wee, Keun Seok Seo, Patrick M Schlievert, Andreas Lengeling, Jos A van Strijp, Victor J Torres, J Ross Fitzgerald
Publikováno v:
PLoS Pathogens, Vol 13, Iss 9, p e1006461 (2017)
Bacterial superantigens (SAgs) cause Vβ-dependent T-cell proliferation leading to immune dysregulation associated with the pathogenesis of life-threatening infections such as toxic shock syndrome, and necrotizing pneumonia. Previously, we demonstrat
Externí odkaz:
https://doaj.org/article/ae54e40195464ed8bfce66dbe8119856
Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.
Autor:
Hanne Amdahl, Karita Haapasalo, Lydia Tan, Taru Meri, Pentti I Kuusela, Jos A van Strijp, Suzan Rooijakkers, T Sakari Jokiranta
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172675 (2017)
Staphyloccus aureus is a major human pathogen leading frequently to sepsis and soft tissue infections with abscesses. Multiple virulence factors including several immune modulating molecules contribute to its survival in the host. When S. aureus inva
Externí odkaz:
https://doaj.org/article/a09fd23b9a144258a2a3710132229d22
Autor:
Astrid Hendriks, Priscilla F. Kerkman, Meri R.J. Varkila, Jelle L.G. Haitsma Mulier, Sara Ali, Thijs ten Doesschate, Thomas W. van der Vaart, Carla J.C. de Haas, Piet C. Aerts, Olaf L. Cremer, Marc J.M. Bonten, Victor Nizet, George Y. Liu, Jeroen D.C. Codée, Suzan H.M. Rooijakkers, Jos A.G. van Strijp, Nina M. van Sorge
Publikováno v:
Cell Reports Medicine, Vol 5, Iss 9, Pp 101734- (2024)
Summary: Staphylococcus aureus is a major human pathogen, yet the immune factors that protect against infection remain elusive. High titers of opsonic IgG antibodies, achieved in preclinical animal immunization studies, have consistently failed to pr
Externí odkaz:
https://doaj.org/article/87dd9b0611164e17939fce56791b0b44
Autor:
Lisanne de Vor, Bruce van Dijk, Kok van Kessel, Jeffrey S Kavanaugh, Carla de Haas, Piet C Aerts, Marco C Viveen, Edwin C Boel, Ad C Fluit, Jakub M Kwiecinski, Gerard C Krijger, Ruud M Ramakers, Freek J Beekman, Ekaterina Dadachova, Marnix GEH Lam, H Charles Vogely, Bart CH van der Wal, Jos AG van Strijp, Alexander R Horswill, Harrie Weinans, Suzan HM Rooijakkers
Publikováno v:
eLife, Vol 11 (2022)
Implant-associated Staphylococcus aureus infections are difficult to treat because of biofilm formation. Bacteria in a biofilm are often insensitive to antibiotics and host immunity. Monoclonal antibodies (mAbs) could provide an alternative approach
Externí odkaz:
https://doaj.org/article/f9dfe179409a4ffabf19a218bc324d32
Autor:
Angelino T. Tromp, Michiel Van Gent, Joris P. Jansen, Lisette M. Scheepmaker, Anneroos Velthuizen, Carla J.C. De Haas, Kok P.M. Van Kessel, Bart W. Bardoel, Michael Boettcher, Michael T. McManus, Jos A.G. Van Strijp, Robert Jan Lebbink, Pieter-Jan A. Haas, András N. Spaan
Publikováno v:
Toxins, Vol 12, Iss 2, p 106 (2020)
Staphylococcal bi-component pore-forming toxins, also known as leukocidins, target and lyse human phagocytes in a receptor-dependent manner. S-components of the leukocidins Panton-Valentine leukocidin (PVL), γ-haemolysin AB (HlgAB) and CB (HlgCB), a
Externí odkaz:
https://doaj.org/article/a091c2a6eac44a4f91881f0e1ec06696
Autor:
Jos A.G. van Strijp
Publikováno v:
Cell Host & Microbe. 31:687-688
Autor:
Marieke M. Kuijk, Yongzheng Wu, Vincent P. van Hensbergen, Gizem Shanlitourk, Christine Payré, Gérard Lambeau, Jennifer Herrmann, Rolf Müller, Jos A.G. van Strijp, Yvonne Pannekoek, Lhousseine Touqui, Nina M. van Sorge
Methicillin-resistantStaphylococcus aureus(MRSA) has been classified as a high priority pathogen by the World Health Organization underlining the high demand for new therapeutics to treat infections. Human group IIA secreted phospholipase A2(hGIIA) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79003ee9bd34016b85907721e43ce051
https://doi.org/10.1101/2022.02.06.476181
https://doi.org/10.1101/2022.02.06.476181
Autor:
Bruce van Dijk, Lisanne de Vor, Kok van Kessel, Jeffrey S Kavanaugh, Carla de Haas, Piet C Aerts, Marco C Viveen, Edwin C Boel, Ad C Fluit, Jakub M Kwiecinski, Gerard C Krijger, Ruud M Ramakers, Freek J Beekman, Ekaterina Dadachova, Marnix GEH Lam, H Charles Vogely, Bart CH van der Wal, Jos AG van Strijp, Alexander R Horswill, Harrie Weinans, Suzan HM Rooijakkers
Publikováno v:
eLife, Vol 11 (2022)
eLife, 11
eLife, 11
Implant-associated Staphylococcus aureus infections are difficult to treat because of biofilm formation. Bacteria in a biofilm are often insensitive to antibiotics and host immunity. Monoclonal antibodies (mAbs) could provide an alternative approach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea975441d1c76989ff2bd8fedabb64b
https://ruj.uj.edu.pl/xmlui/handle/item/312334
https://ruj.uj.edu.pl/xmlui/handle/item/312334
Autor:
Bruce van Dijk, Lisanne de Vor, Kok van Kessel, Jeffrey S Kavanaugh, Carla de Haas, Piet C Aerts, Marco C Viveen, Edwin C Boel, Ad C Fluit, Jakub M Kwiecinski, Gerard C Krijger, Ruud M Ramakers, Freek J Beekman, Ekaterina Dadachova, Marnix GEH Lam, H Charles Vogely, Bart CH van der Wal, Jos AG van Strijp, Alexander R Horswill, Harrie Weinans, Suzan HM Rooijakkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1316cdc5b545935f37ec8c01c08dbff
https://doi.org/10.7554/elife.67301.sa2
https://doi.org/10.7554/elife.67301.sa2
Autor:
Lisanne, de Vor, Bruce, van Dijk, Kok, van Kessel, Jeffrey S, Kavanaugh, Carla, de Haas, Piet C, Aerts, Marco C, Viveen, Edwin C, Boel, Ad C, Fluit, Jakub M, Kwiecinski, Gerard C, Krijger, Ruud M, Ramakers, Freek J, Beekman, Ekaterina, Dadachova, Marnix Geh, Lam, H Charles, Vogely, Bart Ch, van der Wal, Jos Ag, van Strijp, Alexander R, Horswill, Harrie, Weinans, Suzan Hm, Rooijakkers
Publikováno v:
eLife
Implant-associated Staphylococcus aureus infections are difficult to treat because of biofilm formation. Bacteria in a biofilm are often insensitive to antibiotics and host immunity. Monoclonal antibodies (mAbs) could provide an alternative approach